Human Genome Sciences Inc Asset Turnover Ratio (HGSI), as of second quarter 2012, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Human Genome Sciences Inc  (HGSI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Human Genome Sciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Human Genome Sciences Inc asset turnover ratio, the ability of Human Genome Sciences Inc's assets to generate revenue in the second quarter 2012, increased sequentially to 0.14 in the second quarter (Jun 30 2012), HGSI's balance sheet remain strong.

Within sector 20 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2012 compared to the preceding quarter from to 2879.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HGSI Asset Turnover Ratio (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter		 (Jun 30 2011)
II. Quarter
Y / Y Asset Change -14.08 % 39.51 % -17.3 % - -
Y / Y Revenue Change 142.75 % 77.35 % 114.09 % -33 % -35.92 %
Asset Turnover Ratio (TTM) 0.14 0.11 0.1 0.08 0.11
HGSI's Total Ranking # 2879 # # # #
Seq. Asset Change -11.06 % -6.93 % 43.61 % -27.72 % 44.4 %
Seq. Revenue Change 28.04 % 3.53 % 33.8 % 36.87 % -6.45 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 21
Healthcare Sector # 273
Overall Market # 2879

Asset Turnover Ratio Statistics
High Average Low
0.15 0.13 0.11
(Jun 30 2012)   (Dec 31 2011)




HGSI Company Profile • Back to HGSI Efficiency Comparisons • Compare HGSI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2012, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2012 Assets at quarter ending Jun 30 2012
Seagen Inc   0.40 $ 166.621  Millions$ 419.573  Millions
Reflect Scientific Inc  0.39 $ 1.589  Millions$ 4.092  Millions
Alerislife Inc   0.38 $ 2,608.524  Millions$ 6,797.763  Millions
Gyre Therapeutics Inc   0.38 $ 94.402  Millions$ 246.563  Millions
Non Invasive Monitoring Systems Inc  0.38 $ 0.250  Millions$ 0.653  Millions
Vycor Medical Inc   0.38 $ 1.527  Millions$ 4.019  Millions
Assertio Holdings inc   0.38 $ 59.599  Millions$ 157.806  Millions
Nuo Therapeutics, Inc.  0.38 $ 11.190  Millions$ 29.718  Millions
Momenta Pharmaceuticals inc   0.38 $ 163.491  Millions$ 434.698  Millions
Boston Scientific Corporation  0.36 $ 7,416.000  Millions$ 20,448.750  Millions
Prestige Consumer Healthcare Inc   0.35 $ 492.787  Millions$ 1,405.748  Millions
Pfizer Inc  0.34 $ 64,401.000  Millions$ 188,164.750  Millions
Biomarin Pharmaceutical Inc  0.34 $ 461.939  Millions$ 1,357.092  Millions
Amgen Inc   0.34 $ 16,442.000  Millions$ 49,028.000  Millions
Surmodics Inc   0.33 $ 51.986  Millions$ 155.212  Millions
Biocryst Pharmaceuticals Inc   0.33 $ 26.904  Millions$ 82.760  Millions
Novavax inc   0.32 $ 22.598  Millions$ 69.819  Millions
Ironwood Pharmaceuticals inc   0.32 $ 71.224  Millions$ 221.574  Millions
Amicus Therapeutics inc   0.31 $ 29.839  Millions$ 95.265  Millions
Hologic Inc  0.31 $ 1,881.149  Millions$ 6,032.478  Millions
Amag Pharmaceuticals inc   0.30 $ 78.954  Millions$ 266.215  Millions
Sanara Medtech Inc   0.27 $ 1.420  Millions$ 5.248  Millions
Beam Therapeutics Inc   0.27 $ 2,346.000  Millions$ 8,726.675  Millions
Pacira Biosciences inc   0.26 $ 28.338  Millions$ 107.054  Millions
Alnylam Pharmaceuticals Inc   0.26 $ 82.717  Millions$ 312.728  Millions
Biocorrx Inc   0.26 $ 0.878  Millions$ 3.323  Millions
Ligand Pharmaceuticals Incorporated  0.26 $ 30.056  Millions$ 114.150  Millions
Ionis Pharmaceuticals Inc   0.26 $ 123.691  Millions$ 483.470  Millions
Aeon Global Health Corp.  0.26 $ 3.188  Millions$ 12.463  Millions
Achari Ventures Holdings Corp I  0.23 $ 94.080  Millions$ 407.681  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.